Skip to main content
main-content

Video commentaries

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.


Expert commentaries from clinicians and researchers on clinical studies, guidelines, and topical issues in rheumatology.

EULAR 2019

14-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article

Expert commentary: The FINCH 1 and FINCH 3 trials

John Isaacs comments on the findings from the FINCH 1 and FINCH 3 trials and discusses how filgotinib might fit into the rheumatoid arthritis treatment landscape (2:56).

14-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article

Researcher comment: The FINCH 1 trial

Bernard Combe takes us through the findings from the FINCH 1 trial of filgotinib in rheumatoid arthritis patients with an inadequate response to methotrexate (7:19).

15-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article

Researcher comment: The FINCH 3 trial

Rene Westhovens summarizes the results of the FINCH 3 trial, which investigated filgotinib with and without methotrexate in rheumatoid arthritis patients with no prior methotrexate exposure (3:40).

ACR/ARHP 2018

22-10-2018 | Giant cell arteritis | ACR/ARHP 2018 | Video

Axillary artery ultrasound proposed as first-line imaging test for large vessel giant cell arteritis

Berit Dalsgaard Nielsen discusses Aarhus University study findings showing the potential for ultrasound as a first-line imaging test for diagnosing large vessel inflammation in patients with suspected giant cell arteritis (4:57).

27-10-2018 | Denosumab | ACR/ARHP 2018 | Video

Support for denosumab as a treatment option for osteoporosis in patients treated with glucocorticoids

Kenneth Saag discusses his findings of a superior bone mineral density benefit at 2 years with denosumab versus risedronate in patients with glucocorticoid-related osteoporosis (4:45).

24-10-2018 | Cardiovascular disease | ACR/ARHP 2018 | Video

Looking to collaborative models of care to improve primary prevention of CVD in patients with inflammatory arthritis

Lihi Eder describes a new model of care based on collaboration between cardiologists and rheumatologists to better manage cardiovascular risk factors in patients with inflammatory arthritis (5:56).

EULAR 2018

15-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video

Researcher comment: MRI monitoring may not be justified in RA patients in clinical remission

Signe Møller-Bisgaard discusses her findings from the IMAGINE-RA study looking at the effects of adding the target of no osteitis or bone marrow edema on MRI to a conventional treat-to-target regimen in patients with RA (5:10).

Read the accompanying news story

26-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video

Expert commentary: Trial results on upadacitinib for the treatment of RA

Roy Fleischmann comments on the results of the SELECT-MONOTHERAPY and SELECT-NEXT trials, which provide further evidence for the benefits of upadacitinib in patients with RA (6:18).

Read the accompanying news story

15-06-2018 | Systemic lupus erythematosus | EULAR 2018 | Video

Expert commentary: Promising results with herpes zoster vaccine in SLE patients

Thomas Dörner comments on study results demonstrating that a live attenuated herpes zoster vaccine is well tolerated and provokes an antibody response in patients with SLE (5:14).

Read the accompanying news story here

BSR 2018

03-05-2018 | Juvenile idiopathic arthritis | Conferences | Video

Managing JIA-associated uveitis: The SHARE recommendations

In this video, Athimalaipet Ramanan gives an overview of the key points from the SHARE initiative consensus recommendations on the screening, diagnosis, and management of juvenile idiopathic arthritis-associated uveitis.

ACR/ARHP 2017

09-11-2017 | Juvenile idiopathic arthritis | ACR/ARHP 2017 | Video

Expert commentary: Tapping into technology to manage juvenile idiopathic arthritis

Editorial Board member Sangeeta Sule discusses a trial of an online self-management tool for adolescents with juvenile idiopathic arthritis, and the role of technology and education to manage the condition.

07-11-2017 | ACR/ARHP 2017 | Video

The effects of obesity on the outcomes of rheumatic disorders

Margaret Tsai provides independent comment on three studies exploring the effects of obesity in patients with rheumatic diseases.

08-11-2017 | Osteoporosis | ACR/ARHP 2017 | Video

Expert commentary: Bisphosphonate drug holidays and fracture risk

Linda Russell gives an independent comment on a study showing that suspending bisphosphonate treatment for more than 2 years is associated with increased fracture risk.

Read the accompanying news story

EULAR 2017

16-06-2017 | EULAR 2017 | Video

EULAR 2017 highlights: Jürgen Braun

Jürgen Braun talks about his spondyloarthritis highlights from the EULAR meeting.

This activity is financially supported by Novartis Pharma AG.

15-06-2017 | EULAR 2017 | Video

EULAR 2017 highlights: Peter Nash

Peter Nash discusses his rheumatology highlights from Madrid, including new data on oral small molecules and IL-17 inhibitors.

This activity is financially supported by Novartis Pharma AG.

16-06-2017 | Psoriatic arthritis | EULAR 2017 | Video

EULAR 2017 highlights: Philip Mease

Medicine Matters rheumatology editorial board member Philip Mease summarizes research on new therapeutic agents for psoriatic arthritis presented at the meeting.

This activity is financially supported by Novartis Pharma AG.

Image Credits